Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Drug Combination Details

General Information of the Combination (ID: C59135)
Name Flavopiridol   NP Info  + Anti-CD25 monoclonal antibody   Drug Info 
Structure +
Disease
Anaplastic large cell lymphoma [ICD-11: 2A90]
Investigative [1]
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. Enhancing Drug Efficacy by This Combination
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Experiment 1 Reporting the Effect of This Combination [1]
                    In-vitro Model FCCH1043 CVCL_M518 Adult T acute lymphoblastic leukemia Homo sapiens
MT-2 CVCL_2631 Healthy Homo sapiens
HuT 102 CVCL_3526 Mycosis fungoides and Sezary syndrome Homo sapiens
                    In-vivo Model The xenograft model was established by intraperitoneal injection of 1.5*107 MET-1 cells into SCID/NOD mice.
                    Experimental
                    Result(s)
Combination of the flavopiridol and anti-CD25 monoclonal antibody dramatically enhanced the antitumor effect.
References
Reference 1 Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody. Blood. 2005 Feb 1;105(3):1231-6.
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China